ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE and CEREBROVASCULAR ACCIDENT

Overview

CEREBROVASCULAR ACCIDENT is the #1 most commonly reported adverse reaction for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, manufactured by Bayer HealthCare LLC.. There are 9 FDA adverse event reports linking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE to CEREBROVASCULAR ACCIDENT. This represents approximately 5.0% of all 179 adverse event reports for this drug.

Patients taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE who experience cerebrovascular accident should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CEREBROVASCULAR ACCIDENT is moderately reported among ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE

In addition to cerebrovascular accident, the following adverse reactions have been reported for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE:

• DRUG INEFFECTIVE — 7 reports
• DRUG DEPENDENCE — 5 reports
• MALAISE — 5 reports
• PRODUCT USE ISSUE — 5 reports
• CHOKING — 4 reports
• DIZZINESS — 4 reports
• NAUSEA — 4 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 4 reports
• RECTAL HAEMORRHAGE — 4 reports
• ABDOMINAL DISCOMFORT — 3 reports

Other Drugs Associated with CEREBROVASCULAR ACCIDENT

The following drugs have also been linked to cerebrovascular accident in FDA adverse event reports:

Does ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE cause CEREBROVASCULAR ACCIDENT?

CEREBROVASCULAR ACCIDENT has been reported as an adverse event in 9 FDA reports for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CEREBROVASCULAR ACCIDENT with ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE?

CEREBROVASCULAR ACCIDENT accounts for approximately 5.0% of all adverse event reports for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, making it one of the most commonly reported side effect.

What should I do if I experience CEREBROVASCULAR ACCIDENT while taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE?

If you experience cerebrovascular accident while taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages